Aardvark Therapeutics, Inc. · NASDAQ:AARD
Aardvark Therapeutics, Inc. shareholders
As of Jun 30, 2026, 70 institutions reported holding Aardvark Therapeutics, Inc., 43.6% of its shares. Largest: Decheng Capital LLC, Citadel and Laurion Capital Management LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aardvark Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | 17.9% | no change | Aug 14, 2026 |
| Citadel | 1.28M | 5.9% | +40,389 | Aug 14, 2026 |
| Laurion Capital Management LP | 1.03M | 4.7% | no change | Aug 13, 2026 |
| Vanguard | 644K | 2.9% | +738 | Aug 13, 2026 |
| AQR Capital Management LLC | 480K | 2.2% | +346K | Aug 14, 2026 |
| EcoR1 Capital, LLC | 396K | 1.8% | new | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 300K | 1.4% | no change | Aug 14, 2026 |
| Cantor Fitzgerald, L. P. | 233K | 1.1% | +166K | Aug 19, 2026 |
| BlackRock | 187K | 0.85% | −606K | Aug 7, 2026 |
| Geode Capital | 150K | 0.68% | −160K | Aug 12, 2026 |